Tata 1mg, formerly known simply as 1mg, is a digital healthcare platform operating out of Gurugram, India. Founded in 2015 by Prashant Tandon, Gaurav Agarwal, and Vikas Chauhan, the company provides a range of services including e-pharmacy, diagnostics, e-consultation, and health content. The idea is to make healthcare accessible, understandable, and affordable for every Indian. Since being acquired by Tata Digital in 2021, Tata 1mg has expanded substantially in both services and scale, garnering a current valuation of around $1.25 billion as of 2022. As of March 2025, the platform has about 4,552 employees and continues to make strides in India’s burgeoning digital health sector.
| Attribute | Information |
|---|---|
| Founding Date | April 2015 |
| Headquarters | Gurugram, India |
| Founders | Prashant Tandon, Gaurav Agarwal, Vikas Chauhan |
| Revenue | ₹2,392 crore (FY25) |
| Profits | 65 crore (Profit after tax FY25) |
| Key Investors | Tata Digital, Sequoia Capital, Intel Capital, Omidyar Network, Gates Foundation |
| Industry | Digital Healthcare |
| Number of Employees | 4,552 (as of March 31, 2025) |
Tata 1mg's journey began in April 2015 under the name 1mg. The platform was initially part of Bright Lifecare Private Limited, which had set up operations for Healthkart. However, as public demand for accessible medication information and affordable healthcare options surged, 1mg transitioned into a standalone entity focused on simplifying healthcare accessibility. Its core services revolved around providing detailed medicine information, enabling users to search for medicines by name or ailments, and find suitable generic alternatives. From its inception, 1mg grew rapidly, leveraging its comprehensive database and innovative e-pharmacy model that allowed users to track and order medications conveniently online—laying the foundation for its future success and expansion.
Since its founding, Tata 1mg has rapidly evolved from a digital pharmacy platform into a comprehensive healthcare ecosystem. Key to its expansion has been the strategic acquisition by Tata Digital in 2021, which rebranded the platform to Tata 1mg and set the stage for a period of significant growth and expansion.
Today, Tata 1mg operates as a critical player in India's digital healthcare sector. The platform is well-integrated, enabling users to access a variety of services that include but are not limited to, online pharmacy orders, lab tests, teleconsultations, and health information. Tata 1mg’s adaptability to both online and offline modalities set it apart from competitors. It holds a 31% market share, serving millions of customers across various cities, and continues to leverage Tata Group’s resources and network to extend its reach.
Tata 1mg stands as a pivotal force within the Indian digital healthcare realm. As healthcare continues to digitalize, Tata 1mg is strategically positioned to capitalize on growing demands for accessible, streamlined healthcare services. Its dedication to expanding healthcare reach while maintaining a high standard of service underscores its importance in the market. With aggressive expansion plans supported by substantial investments, Tata 1mg's trajectory points towards sustained growth, offering promising prospects for future endeavors in improving public health access in India.